Sign in with your email address username.


[Department of Error] Department of Error

Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 2015; 385: 1295–304—In Table 3 of this Article (April 4), the number of mild events in the latanoprost group column were duplicated into the column for number of mild events in the placebo group at the production stage; all have been corrected. Additionally, the number of total serious events in the placebo group has been corrected from 7 to 9, myocardial infarction events from 1 to 2, and number of patients with a cancer diagnosis in the placebo group from 2 to 4.